165 related articles for article (PubMed ID: 21690207)
1. Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate.
Doublier A; Farlay D; Khebbab MT; Jaurand X; Meunier PJ; Boivin G
Eur J Endocrinol; 2011 Sep; 165(3):469-76. PubMed ID: 21690207
[TBL] [Abstract][Full Text] [Related]
2. In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization.
Boivin G; Farlay D; Khebbab MT; Jaurand X; Delmas PD; Meunier PJ
Osteoporos Int; 2010 Apr; 21(4):667-77. PubMed ID: 19597910
[TBL] [Abstract][Full Text] [Related]
3. Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment.
Roschger P; Manjubala I; Zoeger N; Meirer F; Simon R; Li C; Fratzl-Zelman N; Misof BM; Paschalis EP; Streli C; Fratzl P; Klaushofer K
J Bone Miner Res; 2010 Apr; 25(4):891-900. PubMed ID: 20437609
[TBL] [Abstract][Full Text] [Related]
4. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.
Farlay D; Boivin G; Panczer G; Lalande A; Meunier PJ
J Bone Miner Res; 2005 Sep; 20(9):1569-78. PubMed ID: 16059629
[TBL] [Abstract][Full Text] [Related]
5. Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment.
Jobke B; Burghardt AJ; Muche B; Hahn M; Semler J; Amling M; Majumdar S; Busse B
PLoS One; 2011; 6(8):e23638. PubMed ID: 21858188
[TBL] [Abstract][Full Text] [Related]
6. Effects of strontium on the quality of bone apatite crystals: a paired biopsy study in postmenopausal osteoporotic women.
Doublier A; Farlay D; Jaurand X; Vera R; Boivin G
Osteoporos Int; 2013 Mar; 24(3):1079-87. PubMed ID: 23108780
[TBL] [Abstract][Full Text] [Related]
7. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
Boivin G; Meunier PJ
Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
[TBL] [Abstract][Full Text] [Related]
8. Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment.
Li C; Paris O; Siegel S; Roschger P; Paschalis EP; Klaushofer K; Fratzl P
J Bone Miner Res; 2010 May; 25(5):968-75. PubMed ID: 19874195
[TBL] [Abstract][Full Text] [Related]
9. Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure.
Busse B; Jobke B; Hahn M; Priemel M; Niecke M; Seitz S; Zustin J; Semler J; Amling M
Acta Biomater; 2010 Dec; 6(12):4513-21. PubMed ID: 20654744
[TBL] [Abstract][Full Text] [Related]
10. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration.
Boivin G; Deloffre P; Perrat B; Panczer G; Boudeulle M; Mauras Y; Allain P; Tsouderos Y; Meunier PJ
J Bone Miner Res; 1996 Sep; 11(9):1302-11. PubMed ID: 8864905
[TBL] [Abstract][Full Text] [Related]
11. Strontium ranelate--a promising therapeutic principle in osteoporosis.
Boivin G; Doublier A; Farlay D
J Trace Elem Med Biol; 2012 Jun; 26(2-3):153-6. PubMed ID: 22565017
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis.
Ma YL; Marin F; Stepan J; Ish-Shalom S; Möricke R; Hawkins F; Kapetanos G; de la Peña MP; Kekow J; Martínez G; Malouf J; Zeng QQ; Wan X; Recker RR
Bone; 2011 May; 48(5):972-8. PubMed ID: 21262402
[TBL] [Abstract][Full Text] [Related]
13. Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.
Arlot ME; Jiang Y; Genant HK; Zhao J; Burt-Pichat B; Roux JP; Delmas PD; Meunier PJ
J Bone Miner Res; 2008 Feb; 23(2):215-22. PubMed ID: 17922612
[TBL] [Abstract][Full Text] [Related]
14. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study.
Rizzoli R; Chapurlat RD; Laroche JM; Krieg MA; Thomas T; Frieling I; Boutroy S; Laib A; Bock O; Felsenberg D
Osteoporos Int; 2012 Jan; 23(1):305-15. PubMed ID: 21909729
[TBL] [Abstract][Full Text] [Related]
15. Bone matrix quality in paired iliac bone biopsies from postmenopausal women treated for 12 months with strontium ranelate or alendronate.
Falgayrac G; Farlay D; Ponçon C; Béhal H; Gardegaront M; Ammann P; Boivin G; Cortet B
Bone; 2021 Dec; 153():116107. PubMed ID: 34260980
[TBL] [Abstract][Full Text] [Related]
16. Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis.
Rizzoli R; Laroche M; Krieg MA; Frieling I; Thomas T; Delmas P; Felsenberg D
Rheumatol Int; 2010 Aug; 30(10):1341-8. PubMed ID: 20512336
[TBL] [Abstract][Full Text] [Related]
17. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years.
Hiligsmann M; Bruyère O; Reginster JY
Bone; 2010 Feb; 46(2):440-6. PubMed ID: 19716940
[TBL] [Abstract][Full Text] [Related]
19. Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride.
Pemmer B; Hofstaetter JG; Meirer F; Smolek S; Wobrauschek P; Simon R; Fuchs RK; Allen MR; Condon KW; Reinwald S; Phipps RJ; Burr DB; Paschalis EP; Klaushofer K; Streli C; Roschger P
J Synchrotron Radiat; 2011 Nov; 18(Pt 6):835-41. PubMed ID: 21997907
[TBL] [Abstract][Full Text] [Related]
20. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial.
Meunier PJ; Slosman DO; Delmas PD; Sebert JL; Brandi ML; Albanese C; Lorenc R; Pors-Nielsen S; De Vernejoul MC; Roces A; Reginster JY
J Clin Endocrinol Metab; 2002 May; 87(5):2060-6. PubMed ID: 11994341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
